Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of GLPG1972 in Osteoarthritis
NCT03311009Phase 1Completed
- Sponsor
- Galapagos NV
- Start
- May 2017
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in osteoarthritis (OA) comparing GLPG1972 with Placebo (2 arms). Primary endpoints: Number of Adverse Events at Day 50, Abnormal Vital Signs at Day 50 and 8 more. Started May 2017; status: completed.
02
Drugs
GLPG1972
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03311009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03311009.